Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging.
Study Goal
The researchers aimed to review the role of oxidative stress in various diseases and the potential of antioxidants, including melatonin, to mitigate its harmful effects.
Results Summary
The abstract highlights melatonin as one of the small molecular weight antioxidants that can ameliorate oxidative stress, though it does not provide specific efficacy data for melatonin alone. It suggests that antioxidants, including melatonin, play a role in combating oxidative damage linked to various pathologies.
Population
Not specified (general review of oxidative stress mechanisms and antioxidant roles).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
antioxidants | decrease | oxidative stress | - | - | ameliorate the harmful effect | #1 |
antioxidant enzymes (Superoxide dismutases-SODs, catalase, glutathione peroxidase-GPx) | decrease | harmful effect of oxidative stress | - | - | achieve concerted action | #2 |
small molecular weight antioxidants (vitamins C and E, flavonoids, carotenoids, melatonin, ergothioneine, and others) | decrease | harmful effect of oxidative stress | - | - | achieve concerted action | #3 |
vitamin E | decrease | peroxidation of lipids | - | - | first line of defense | #4 |
certain antioxidants (e.g. flavonoids) | decrease | cancer | - | - | showing weak prooxidant properties that may boost cellular antioxidant systems and thus act as preventive anticancer agents | #5 |
Redox metal-based enzyme mimetic compounds | neutral | - | - | - | potential pharmaceutical interventions | #6 |
sirtuins | neutral | age-related diseases and anti-aging strategies | - | - | promising therapeutic targets | #7 |
A physiological level of oxygen/nitrogen free radicals and non-radical reactive species (collectively known as ROS/RNS) is termed oxidative eustress or "good stress" and is characterized by low to mild levels of oxidants involved in the regulation of various biochemical transformations such as carboxylation, hydroxylation, peroxidation, or modulation of signal transduction pathways such as Nuclear factor-κB (NF-κB), Mitogen-activated protein kinase (MAPK) cascade, phosphoinositide-3-kinase, nuclear factor erythroid 2-related factor 2 (Nrf2) and other processes. Increased levels of ROS/RNS, generated from both endogenous (mitochondria, NADPH oxidases) and/or exogenous sources (radiation, certain drugs, foods, cigarette smoking, pollution) result in a harmful condition termed oxidative stress ("bad stress"). Although it is widely accepted, that many chronic diseases are multifactorial in origin, they share oxidative stress as a common denominator. Here we review the importance of oxidative stress and the mechanisms through which oxidative stress contributes to the pathological states of an organism. Attention is focused on the chemistry of ROS and RNS (e.g. superoxide radical, hydrogen peroxide, hydroxyl radicals, peroxyl radicals, nitric oxide, peroxynitrite), and their role in oxidative damage of DNA, proteins, and membrane lipids. Quantitative and qualitative assessment of oxidative stress biomarkers is also discussed. Oxidative stress contributes to the pathology of cancer, cardiovascular diseases, diabetes, neurological disorders (Alzheimer's and Parkinson's diseases, Down syndrome), psychiatric diseases (depression, schizophrenia, bipolar disorder), renal disease, lung disease (chronic pulmonary obstruction, lung cancer), and aging. The concerted action of antioxidants to ameliorate the harmful effect of oxidative stress is achieved by antioxidant enzymes (Superoxide dismutases-SODs, catalase, glutathione peroxidase-GPx), and small molecular weight antioxidants (vitamins C and E, flavonoids, carotenoids, melatonin, ergothioneine, and others). Perhaps one of the most effective low molecular weight antioxidants is vitamin E, the first line of defense against the peroxidation of lipids. A promising approach appears to be the use of certain antioxidants (e.g. flavonoids), showing weak prooxidant properties that may boost cellular antioxidant systems and thus act as preventive anticancer agents. Redox metal-based enzyme mimetic compounds as potential pharmaceutical interventions and sirtuins as promising therapeutic targets for age-related diseases and anti-aging strategies are discussed.